Novo Integrated Sciences, Inc.
NVOS · OTC
8/31/2024 | 8/31/2023 | 8/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,675 | $14,232 | $48,489 | $45,089 |
| - Cash | $845 | $416 | $2,179 | $8,293 |
| + Debt | $4,710 | $4,472 | $12,996 | $13,708 |
| Enterprise Value | $9,540 | $18,287 | $59,306 | $50,505 |
| Revenue | $13,294 | $12,572 | $11,738 | $9,305 |
| % Growth | 5.7% | 7.1% | 26.1% | – |
| Gross Profit | $5,743 | $4,953 | $4,799 | $3,823 |
| % Margin | 43.2% | 39.4% | 40.9% | 41.1% |
| EBITDA | -$10,076 | -$5,849 | -$22,480 | -$2,582 |
| % Margin | -75.8% | -46.5% | -191.5% | -27.7% |
| Net Income | -$16,129 | -$13,215 | -$32,849 | -$4,462 |
| % Margin | -121.3% | -105.1% | -279.9% | -48% |
| EPS Diluted | -0.9 | -1.3 | -11.28 | -1.8 |
| % Growth | 30.8% | 88.5% | -526.7% | – |
| Operating Cash Flow | -$2,243 | -$2,243 | -$5,884 | -$1,025 |
| Capital Expenditures | -$49 | -$49 | -$190 | -$256 |
| Free Cash Flow | -$2,293 | -$2,293 | -$6,074 | -$1,281 |